Future Patient - Telerehabilitation of Patients With Atrial Fibrillation
(FP-AF)
1 other identifier
interventional
208
1 country
1
Brief Summary
This project has focus on patients with atrial fibrillation testing a telerehabilitation program for patients with atrial fibrillation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 26, 2023
CompletedFirst Posted
Study publicly available on registry
October 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedOctober 26, 2023
October 1, 2023
2.1 years
June 26, 2023
October 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in AF specific health-related quality of life
The Atrial Fibrillation Effect on quality of life questionnaire (AFEQT) is a 20-item self-administered questionnaire designed to assess the impact of AF on the patients' health-related quality of life (HRQoL) across symptoms, daily activities, treatment concerns, and treatment satisfaction. Scores range from 0-100, with higher scores indicating better HRQoL
For both intervention and control group: QoL will be measured at baseline, end of telerehabilitation (16 weeks) and after 28 weeks
Secondary Outcomes (25)
Changes in AF knowledge
For both intervention and control group: To be measured at baseline, end of telerehabilitation (16 weeks) and after 28 weeks
Measurement of weight
Intervention group: Weight will be measured at baseline, twice a week, and as needed up to 16 weeks
Measurement of bloodpressure
Intervention group: Bloodpressure will be measured at baseline, twice a week, and as needed up to 16 weeks
Measurement of pulse
Intervention group: Pulse will be measured at baseline, everyday, and as needed up to 16 weeks
Measurement of steps
Intervention group: Steps will be measured from the date of randomization, everyday to end follow up (28 weeks)
- +20 more secondary outcomes
Study Arms (2)
Telerehabilitation group
EXPERIMENTALThe telerehabilitation group (n=104) will participate in the FP-AF program for 16 weeks. The program is administered by the AF clinics and the healthcare centers (HC) in Viborg, Skive and Silkeborg Municipalities. After enrollment, the patients will have an individual meeting with the project nurse. Here the patient (and relatives, if necessary) will be instructed in the use of the technologies and an individual plan will be formulated for the AF patient's telerehabilitation. After participation in 16 weeks the patients start a 12 weeks follow-up period, where they will only measure steps and have access to the Heartportal on their own devices.
Conventional rehabilitation
NO INTERVENTIONThe control group (n=104) will follow the conventional care regime in the AF clinic and will not have contact to the project nurse. When the AF patients are in a stable condition, they will be followed by their general practitioner (GP). The control group will be in the study for 28 weeks.
Interventions
Telerehabilitation platform: Hjerteportalen, blood pressure monitor (iHealth(neo/BP5s), weight scale (iHealth Lina), Activity tracker (FitBit inspire 3), ECG monitor (AliveCor KardiaMobile), sleep sensor (Emfit QS), video consultation (VDX by MedCom)
Eligibility Criteria
You may qualify if:
- Patients diagnosed with atrial fibrillation
- Adults over 18 years
- Living in Skive, Viborg or Silkeborg Municipalities
- Living at home and capable of caring for themselves
- Have basic computer skills or having a relative/friend with basic computer skills
You may not qualify if:
- Pregnancy
- Refusal or inability to cooperate; or patient not does not speak, read or understand Danish
- Life expectancy less than a year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aalborg Universitylead
- Department of Cardiology, Viborg Regional Hospitalcollaborator
- Department of Cardiology, Silkeborg Regional Hospitalcollaborator
- Center for Innovative Medical Technologies (CIMT), Odense University Hospitalcollaborator
- Laboratory for Welfare Technology, Department of Health Science and Technology, Aalborg Universitycollaborator
Study Sites (1)
Central Jutland Regional Hospital
Viborg and Silkeborg, Denmark
Related Publications (1)
Dinesen B, Albertsen AE, Joensen EDR, Spindler H, Jensen KM, Kidholm K, Frost L, Dittman L, Gunasegaram M, Johnsen SP, Jochumsen MR, Svenstrup D. Future Patient-Telerehabilitation of Patients With Atrial Fibrillation: Protocol for a Multicenter, Mixed Methods, Randomized Controlled Trial. JMIR Res Protoc. 2025 Feb 18;14:e64259. doi: 10.2196/64259.
PMID: 39965197DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Birthe Dinesen, MSc, Ph.D
Aalborg University
- STUDY DIRECTOR
Dorthe Svenstrup, MD, Ph.D
Central Jutland Regional Hospital, Viborg
- STUDY DIRECTOR
Lars Frost, MD, Ph.D, DMSc
Central Jutland Regional Hospital, Silkeborg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 26, 2023
First Posted
October 26, 2023
Study Start
January 1, 2023
Primary Completion
February 1, 2025
Study Completion
June 30, 2025
Last Updated
October 26, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share
No plan for sharing protocol as we are applying for patent.